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A comparative study of electronic cigarette vapour extracts on airway-
related cell lines in vitro 
The use of electronic cigarettes (ECs) is rapidly increasing worldwide, however 
scientific evidence regarding EC cytotoxicity is limited. The aim of this study was to 
evaluate the acute cytotoxicity of EC vapour extract (ECE) on airway-related cells in 
vitro. 
Cigarette smoke extract (CSE), vapour extract of fifteen brands/flavours of ECs and the 
extract from the E-vehicle (propylene glycol and glycerine) was collected. Extracts, in 
concentrations of 100% to 12.5%, were added to human bronchial epithelial (BEAS-
2B, IB3-1 and C38), fibroblast (Wi-38) and macrophage (J774 and THP-1) cell lines. 
Viability was assessed after 24 hours using a standard XTT assay. Viability of less than 
70% of control (no extract) was considered cytotoxic according to UNI EN ISO 10993-
5 standards.  
CSE displayed a concentration-dependent influence on cell viability across all four cell 
lines with 100% producing the most toxic effect, therefore validating the model. ECEs 
reduced viability although this was not correlated with nicotine content or the E-
vehicle. However, several flavours proved cytotoxic, with variation between different 
brands and cell lines. 
These data indicate that not all ECs are the same and that use of a particular flavour or 
brand may have differing effects. The cell line used is also an important factor. More 
research is crucial to ascertain the health effects of different ECs before they can be 
accepted as a safe alternative to tobacco cigarettes. 
Keywords: Electronic cigarettes; airways; cytotoxicity; epithelials; in vitro models 
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Introduction 
Electronic cigarettes (EC) first emerged onto the market in China in 2004 and entered the US 
market in 2007 (Regan et al. 2013). Advertised as a safe alternative to traditional tobacco 
cigarettes, EC were soon introduced across different countries and their market has steadily 
risen. According to the UK’s public health charity, Action on Smoking and Health (ASH), 
2.6 million adults in Great Britain currently use EC (ASH 2015). There has been a rapid 
global progression amongst high and low income countries, with EC use stabilising at around 
17% of adult smokers, although awareness of these products is much higher, according to 
data pulled together in a recent Public Health England report (Britton and Bogdanovica 
2014).  
 
The body of research performed on the acute and chronic effects of ECs on human 
health is limited (Breland et al. 2014). There are a number of challenges associated with EC 
research. The lack of a standardised testing protocol to evaluate different products means that 
there is no consensus between academic researchers, manufacturers and stake-holders (Orr 
2014). Proper toxicological evaluations of ECs by the regulatory bodies are also lacking. 
 
The liquid component of EC, known as E-liquid, has been studied, and these reports 
show that there are a number of variations and complications in terms of these analyses (e.g. 
Bahl et al. (2012) and Misra et al. (2014)). Unlike tobacco cigarettes, which have defined 
nicotine yields on the packaging, the nicotine content of E-liquids is simply labelled as ‘low’, 
‘medium’, or ‘high’; the precise concentration is not defined. In some cases this has been 
found to be inaccurate (Cameron et al. 2014) with E-liquids labelled as ‘nicotine free’ 
containing detectable levels of nicotine (FDA 2014).  
 
4 
 
Harmful, tobacco specific nitrosamines (TSNA), such as 4-(methylnitrosamino)-1-(3-
pyridyl)-1-butanone (NNK) and N9-nitrosonor-nicotine (NNN) (Goniewicz et al. 2014), 
along with the minor tobacco alkaloids, anabasine and myosmine (FDA 2014), have been 
shown to be present in EC vapours, at levels such that EC smoking (“vaping”) can result in 
equivalent formaldehyde exposure as cigarette smoking (Goniewicz, Knysak, Gawron, 
Kosmider, Sobczak, Kurek, Prokopowicz, Jablonska-Czapla, Rosik-Dulewska and Havel 
2014). The lack of any clear labelling and the apparent differences between the 
concentrations of components in identical bottles of EC refill fluids (Behar et al. 2014) 
complicate the evaluation of different ECs, EC liquids and the volatiles released in EC 
vapour. The contents of EC and EC liquid (for refillable EC) and the efficiency of 
vapourising differ between different brands, flavours, manufacturers and EC designs and 
therefore make comprehensive analysis of potential adverse health effects of EC very 
challenging.  
 
Studies of EC vapour extract (ECE) on human cells are extremely limited. Data thus 
far predominantly includes work performed on non-human cell lines including rat 
cardiomyoblasts (Farsalinos, Romagna, Allifranchini, et al. 2013) and mouse fibroblasts 
(Romagna et al. 2013). There have been some studies using whole EC vapour in cell 
exposure experiments. In a recent study funded by British American Tobacco, Nielson et al. 
(2015), used commercially available cell culture models of the human airways to examine 
ECE toxicity in comparison to tobacco cigarette exposure. The study concluded that EC were 
less toxic than tobacco but the limitations of the study were that ECE exposure was limited to 
the same flavoured EC with two different nicotine concentrations. 
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Exposure to EC contents, in the form of the E-liquid, has been studied in vitro.  For 
example, Bahl et al (2012) exposed various cell types, including human pulmonary 
fibroblasts, to refill fluids from three different manufacturers and found no correlation 
between cytotoxicity and nicotine content. Importantly, this study did show differences in 
IC50 for doses of 0-1% of the refills for different brands/flavours and different susceptibility 
for different cell types. This association of varying cytotoxicity with the flavourings used has 
been verified with other studies (Farsalinos, Romagna, Allifranchini, Ripamonti, Bocchietto, 
Todeschi, Tsiapras, Kyrzopoulos and Voudris 2013). Cinnamon flavoured EC liquids in 
particular have been found to be relatively more cytotoxic than other flavours tested (Bahl, 
Lin, Xu, Davis, Wang and Talbot 2012, Behar, Davis, Wang, Bahl, Lin and Talbot 2014). 
 
The main aim of this research is to study the effects of ECE on cultured human 
bronchial epithelial cells and macrophages in-vitro, something which to date has not been 
shown in the literature. Here we analyse the effects of a large variety of EC brands, nicotine 
concentrations and flavourings, as well as the vehicle which delivers these constituents, on 
epithelial cells, fibroblasts and macrophages, in order to establish useful data on the potential 
cytotoxicity of these devices. 
 
Materials and Methods 
Cigarettes and ECs 
A number of branded ECs were purchased from consumer websites. Marlboro Reds (Philip 
Morris International, New York, USA) were employed as standard tobacco cigarettes for 
validation purposes. The anonymised EC brands are listed in table 1, along with the 
information provided by the manufacturer on nicotine content and other additives. 
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Cell Culture 
Seven cell lines in total were used in the current work to investigate the toxicity of EC; Four 
human derived bronchial epithelial cell lines, BEAS-2B, IB3-1, C38 and CALU-3, two 
macrophage cell lines, namely J774, a mouse macrophage and THP-1 a monocyte-derived 
macrophage and Wi-38, a human derived fibroblast cell line. These were selected in order to 
test the effects of ECE on the most relevant cell types likely to be affected by vaping; namely 
the bronchial epithelial cells lining the upper respiratory tract, the underlying fibroblast cells, 
and the macrophages, defensive cells that patrol the airways to maintain sterility and 
minimise damage. All cell lines were originally available from the ATCC (LGC Standards, 
Middlesex, UK). All cell culture consumables were from Thermo Scientific Ltd 
(Loughborough, UK). 
 
Epithelial cell lines were all maintained in DMEM-F12 (1:1 ratio of Dulbecco’s 
Modified Eagle’s Medium and Ham’s F12) supplemented with 50 U/mL penicillin, 50 µg/mL 
streptomycin and 10% (v/v) serum (FBS). Fibroblasts were cultured in EMEM (Eagle’s 
minimum essential medium) supplemented with 50 U/mL penicillin, 50 µg/mL streptomycin 
and 10% (v/v) serum (FBS). J774 and THP-1 cell culture medium consisted of RPMI 1640 
(Roswell Park Memorial Institute medium) supplemented with 2 mM L-Glutamine, 50 U/mL 
penicillin, 50 µg/mL streptomycin and 10% (v/v) serum (FBS). When using the THP-1 cell 
line the cells were cultured for 48h with 250nm Phorbol 12-Myristate 13-Acetate (PMA) at 
2x105 prior to exposure to induce differentiation to macrophage-like cells (Thomas et al. 
2013).  All cell lines were cultured at 5% CO2 and 37°C. Culture medium was changed three 
times per week and all cell cultures were examined microscopically daily in order to monitor 
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any changes in viability (reduction in adherence) or morphology that would indicate bacterial 
infection.  
 
Extract Collection 
Cigarette Smoke Extract (CSE), E-vehicle Extract (EVE) and EC vapour extract (ECE) were 
obtained based on accepted methodologies (Carp and Janoff 1978). The technique allows the 
water-soluble components of the ECs and cigarette to be applied to the cell cultures. 
However, the water-insoluble components in this methodology are not considered. In brief, a 
lit cigarette or activated EC was attached to the inflow tube of the apparatus (Figure 1). A 
12V power supply unit (Manson Engineering Industrial Ltd, Hong Kong) was used to 
activate a diaphragm pump (Gardner Denver Ltd., Germany) and draw the cigarette 
smoke/EC vapour through the inflow tube and into the small sterile glass bottle, containing 
10 mL of appropriate sterile cell culture medium. This was performed over a time period of 2 
seconds, drawing through 35 mL, followed by a pause of 28 seconds before repeating (ISO 
1991). Flow rates were monitored and regulated via an integral flow meter (Key Instruments, 
Trevose, PA, USA). The time taken to smoke the whole cigarette completely was 
approximately 7 minutes involving 14 puffs. ECE was obtained in a similar process involving 
the same puff rate, puff duration and total number of puffs as CSE. Individual sets of tubes 
and bottles were used for either cigarettes or ECs to minimise the chance of cross 
contamination. All bottles and tubes were thoroughly washed and autoclaved between uses. 
The CSE and ECE were collected (100% concentration) and were serially diluted in medium 
to dilutions of 50%, 25% and 12.5%. The EVE was collected at 100% concentration and was 
not diluted. All extracts were collected shortly before (less than one hour) being applied to 
the cells. 
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Exposure of cell lines to CSE, EVE or ECE 
For experiments using the epithelial cells, 1 mL of 3x105 cells/mL were seeded into each 
well of a 24-well plate and incubated overnight at 5% CO2, 37°C. Fibroblasts were plated in 
a similar fashion except that the seeding density was 1x105 cells/mL/well and for the 
monocytes it was 2x105 cells/mL/well. After twenty four hours, after the cells had formed a 
confluent monolayer, the existing medium was aspirated from each well and immediately 
replaced with medium containing the CSE, EVE or ECE. 1 mL of each dilution of CSE or 
ECE (100%, 50%, 25% and 12.5%) was added into the appropriate wells. Control samples 
were cells submerged in untreated medium. Plates were incubated at 37°C and 5% CO2 for 
twenty four hours.  
 
Cell viability analysis 
XTT was made up to 1 mg/mL in PBS and added to 1 mM menadione in acetone at a ratio of 
12.5:1. 250 µL of this solution was added to each well containing the extracts or untreated 
medium and incubated at 37°C for 2 hours. After this time, 100 µL of the supernatant from 
each well was transferred in triplicate to a 96 well microplate and the absorbance read at 450 
nm using a spectrophotometer (MultiSkan, ThermoScientific, USA). The same procedure 
was followed for all replicates of each experimental condition. 
 
Statistical analysis 
All experiments were repeated at least four times, with four replicate wells of each condition 
tested for each repeat. Two-way ANOVA was performed, followed by a Tukey-Kramer post-
hoc test. All statistical tests were performed in GraphPad®, V6 (GraphPad Software Inc., La 
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Jolla, CA, USA).  
 
Results 
Effects of CSE 
Cigarette smoke extract (CSE) was obtained using established techniques, the experimental 
methodology of which has been shown to provide useful similarities to the in vivo situation 
(Bernhard et al. 2004).  The cells were exposed to this CSE in order to validate our methods. 
Figure 2 represents the cell viability of three epithelial cell lines (IB3-1, C38 and BEAS-2B) 
and one macrophage cell line (J774) after 24 hours exposure to different concentrations of 
CSE. The results show that there was a dose-dependent decrease in cell viability such that 
viability was significantly less than control for all cell types and for all concentrations of CSE 
tested. Cytotoxicity, defined when viability was below 70% of the control, according to the 
ISO standard UNI EN ISO 10993-5, occurred in the C38 cell line at all concentrations of the 
CSE (Figure 2B), and at concentrations of 25% and higher for the other cell types tested.   
 
Effects of EVE 
In order to ascertain the effects of the basic constituents within ECs, the vehicle with which 
the EC nicotine and flavours are delivered was investigated. The combination of propylene 
glycol (PG) and glycerine (G) was investigated at several ratios. Extracts from these ratios 
was added to BEAS-2B under submerged culture. The results are shown in figure 3 with the 
control value being that of cells with medium only added i.e. no EVE. The viability of cells 
was not linearly related to the ratio of PG:G. 
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Effects of ECE 
Several brands of ECs were purchased and the ECE was obtained as described. Cells were 
exposed to 1 mL of ECE for 24 hours, viability was measured and cytotoxicity was defined 
as above. When the cells were exposed to ECE from different brands, there was a decrease in 
the cell viability compared to the control, but this differed for different brands and different 
cell types. All data from the four main cell lines used are shown in Table 2.  
 
 
The effect of differing nicotine content within the same brand 
In order to assess the effects of EC nicotine concentration on cell viability, results were 
compared across three epithelial cell lines (IB3-1, C38 and BEAS-2B) and two macrophage 
cell lines (J774 and THP-1) following 24 hours exposure to Brand D ECE. This brand 
contains EC with nicotine concentrations of 6, 12 and 18 mg stated as on the packaging, and 
in each case, the flavouring is labelled as ‘Tobacco’. The results (figure 4) show that there 
were significant decreases in the viability compared to the control, and this was true for all 
five cell lines. However, there is not a concentration-dependent relationship between 
increasing nicotine content and decreasing cell viability, suggesting that the drop in viability 
was not simply due to nicotine content. None of the ECE tested here were cytotoxic (i.e. 
resulted in cell viability <70% control). 
 
The effect of different flavourings within the same brand 
Four different flavours from EC Brand E were used to study the effects of EC flavourings 
upon cell viability. Results, as shown in figure 5, indicate that some flavourings result in 
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cytotoxicity but others do not, within the same brand, and at the same nicotine concentration. 
When cells were exposed to 100% strawberry flavoured ECE, cytotoxicity was demonstrated 
for cell types C38, BEAS-2B, IB3-1 and ranged from 66.9±2.8% control (IB3-1 cells) to 
43.6±3.6% control (BEAS-2B cells). Strawberry flavoured ECE proved cytotoxic to both the 
C38 and the BEAS-2B cell lines at all concentrations (figure 5B and 5C for C-38 and BEAS-
2B respectively). Cherry flavoured ECE was similarly damaging to the C38 and BEAS-2B 
cell lines, with cytotoxicity displayed at dilutions of 25% and higher and, in the case of 
BEAS-2B, tobacco flavoured ECE also proved cytotoxic at all dilutions tested. In addition, 
CALU-3 cells were exposed to the same flavoured ECEs as shown in Figure 5 at 100% 
dilution only. For this cell line, there was no significant difference between the viability of 
the exposed cells compared to the control for any of the flavours tested. 
 
Two-way ANOVA was also performed in order to analyse the difference between the 
effects of different flavours. Since strawberry was found to demonstrate the most 
cytotoxicity, the effect of other flavours were compared to that of strawberry across all 
concentrations. The effect of strawberry flavour on the BEAS-2B cell line was statistically 
significantly different from the effect of apple, cherry and tobacco at all concentrations i.e. 
strawberry flavouring was more cytotoxic (statistically) than the other flavourings at all 
concentrations tested. In IB3-1, C38 and J774, at 100% ECE concentration, the effect of 
strawberry flavour was statistically significantly different compared to other flavours. At 
other ECE concentrations, this varied. The results of this statistical analysis can be seen in 
Table 3. 
 
The Strawberry flavour proved most cytotoxic of all the flavours tested and so this EC 
was again tested using two additional cell lines; THP-1 and Wi-38. The results showed no 
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relationship between ECE concentration and cell viability and there was no cytotoxicity 
demonstrated at any concentration on either cell line, with cell viability reaching minimum 
levels of 83% and 104% of controls, for THP-1 and Wi-38 respectively, across the varying 
concentrations of ECE. 
 
The effect of the same flavouring within different brands 
All results are shown in Figure 6. Of the cell lines tested under these conditions, BEAS-2B 
were the most sensitive cell type, with viability falling to 22.4±3.7% of control after exposure 
to 100% ECE Brand C, and 48.8±5.3% of control following exposure to 100% Brand E. The 
other cell lines showed varying results, with cytotoxicity observed for some cell types with 
some brands, but this was not consistent across either different cell types or different brands. 
Brand B was cytotoxic only to IB3-1 cells at 100% ECE, whilst Brand D did not induce any 
cytotoxicity in any of the cell lines tested. 
 
 
Discussion 
The current study aimed to analyse the effects of CSE and ECE on four cell lines; namely, 
three human bronchial epithelial cell lines (BEAS-2B, IB3-1 and C-38), and one macrophage 
cell line (J774). Using these four different cell lines allowed comparison of the potentially 
damaging effects of CSE and ECE. Further studies were then performed using additional cell 
types, fibroblasts (Wi-38), epithelials (CALU-3) and monocytes (THP-1) based on the 
results. This is the first study on the influence of CSE and ECE on cytotoxicity for these cell 
types.  
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Using smoke or vapour extract on submerged cells to examine viability and 
cytotoxicity is an established methodology. Whilst not as physiologically relevant as work 
involving models at the air-liquid-interface (ALI) such as the study by Neilson et al (2015), 
the methodology used has allowed us to test a large range of brands and flavours; fifteen in 
total, at four concentrations, across four cell lines, performed in quadruplicate. A number of 
these tests were then repeated using the additional cell lines; THP-1, Wi38 and CALU-3. This 
has allowed us to determine which ECs have the most potential to cause cytotoxicity under 
these conditions. The limitations of this methodology are that the inhalation pattern of ECs 
may not be comparable to that of cigarettes (Farsalinos, Romagna, Tsiapras, et al. 2013), 
though there is currently no standard for ECs, and that the extract will deliver the water 
soluble components of the EC only. These ECs should also be used in future experiments on 
more physiological models such as co-cultures at the ALI where the EC vapour is delivered 
directly to the cell culture. 
 
CSE has a detrimental effect on cell viability  
All four concentrations of CSE tested resulted in a statistically significant difference in 
viability as compared to the control and to each other, in agreement with other studies. This 
result provides partial validation of our methodologies. 
 
The use of CSE to investigate the effects of cigarettes on cultured cells has been 
extensively shown previously (Bernhard, Huck, Jakschitz, Pfister, Henderson, Bonn and 
Wick 2004, Carp and Janoff 1978). The results from our study are in accordance with a 
number of past studies on the toxicity of CSE which show reduction in cell viability even at 
low concentrations. Yoon et al. (2011) showed that there was a significant decrease in the cell 
viability of human bronchial smooth muscle cells (from cell lines) with increasing 
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concentrations of CSE up to 30% concentration. In a study with alveolar type II cells, CSE, at 
5% concentration, caused a reduction in viability, down to 19% of the control after 72 hours 
(Hoshino et al. 2001). There are as yet no standard techniques for generating ECE or for 
exposing cells to ECE, therefore, the data from figure 2 presented here provide confidence in 
these models, in the methodology for the generation of extract (EC or cigarette) and therefore 
in our ability to use data from these model in the analysis of the effects of ECE.  
  
The effect of the E-vehicle 
Extract was obtained using an EC which contained the E-vehicle only. This EVE was 
obtained with varying ratios of PG:G (figure 3). No concentration-dependent relationship was 
found between increasing ratios of PG:G and cell viability. Some statistically significant 
decreases in cell viability were found, though with a wide variability in data. Scheffler et al. 
(2015) investigated the effects of pure PG and G vapour on cultured primary bronchial cells 
at air liquid interface. The results showed a decrease in cell viability compared to the cells 
exposed to air only. However, there is little in the literature which assesses the effects of the 
extracts from PG and G, or indeed the combination of the two as seen in ECs.  
 
The effect of nicotine concentration  
Our results are consistent with previous work performed on EC cytotoxicity. Farsalinos et al. 
(2013) concluded that nicotine concentration had no effect on myocardial cell survival when 
comparing different ECEs, and Bahl et al. (2012) reported that cells did not survive better in 
samples without nicotine when subjected to direct e-liquid exposure. Cervellati (2014) 
however, showed that nicotine did have an effect on the viability and inflammatory response 
of cells exposed to EC vapour, though this was not using ECE. 
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The mechanisms of actions of nicotine in terms of protection versus cytotoxicity are 
not clearly understood. Nevertheless, it is interesting to note that previous works on nicotine 
have focused on its anti-apoptotic properties (Argentin and Cicchetti 2004, Argentin and 
Cicchetti 2006, Laytragoon-Lewin et al. 2011). Hence, though the mechanism by which the 
cells are not damaged by increasing nicotine doses in ECE as seen here is unclear, the fact 
that nicotine does not have any major influence on the cell viability is well established, and 
our own findings support this. 
 
Relationship between EC flavourings and cell viability   
As shown in figure 5, the different flavourings tested caused a varied outcome in cell viability 
across the four cell lines, with BEAS-2B appearing the most susceptible, whereas CALU-3 
showed no cytotoxic response to any of the four flavours tested. 
 
Although the flavourings used in E-liquid fabrication are often common food 
additives, the effects of these additives once heated and aerosolised, in conjunction with the 
other constituents is still largely unknown. Additional variability may come from the type and 
amount of flavourings included in the EC which vary between manufacturers, with the 
potential to affect the cytotoxicity. Moreover, even the method of production of natural 
flavourings such as ‘tobacco’ or ‘coffee’ and ‘cinnamon’ are different among the various 
manufacturers. Bahl et al. (2012) showed that the cytotoxic effect of ECs on human 
pulmonary fibroblasts was due to the concentration of chemicals used to produce different 
flavours. The concentration of these chemicals varied even between flavoured liquids 
purchased from the same manufacturer. ECs with various flavours have been shown to result 
in particular effects on in vitro cell lines, and cinnamon flavourings have been particularly 
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noted in the literature (Bahl, Lin, Xu, Davis, Wang and Talbot 2012, Behar, Davis, Wang, 
Bahl, Lin and Talbot 2014, Lerner et al. 2015).  
 
The constituents of ECs cannot be assumed to be completely non-toxic or safe. For 
example, the presence of formaldehyde-releasing agents has been found in EC vapour 
(Jensen et al. 2015) and the main ingredient of cinnamon flavour, cinnamaldehyde, is 
converted to benzaldehyde at high temperatures (Friedman et al. 2000)Our own results 
support that the flavourings used in ECs affect the potential cytotoxicity of the EC vapour. 
 
Relationship between the same flavour, different brands with cell viability   
Analysis of the different flavoured ECE indicated that there are significant differences in the 
cytotoxic effects within one brand, and thus there is a concern that flavour choice may 
influence the health effects of EC. We also wanted to examine the effects of one flavour 
(tobacco) across different brands (Brand B, C, D and E). These data indicate that there are 
significant differences in the contents of EC, despite similar packaging labelling (e.g. all 
brands tested here simply declared Tobacco Flavourings). This suggests that there is a 
requirement for more rigorous indication of content and further testing of the different EC 
products. If EC are to be used as a safe alternative to tobacco or nicotine replacement 
products for smoking cessation (ASH 2015), then the consumer needs to know the precise 
contents, and the smoking cessation clinics and advisors need to know the likely health 
effects, since our data indicate that not all EC are the same. 
 
The effect of different cell types 
In this study we employed a total of seven different cell types for various experiments. Four 
17 
 
of these were bronchial epithelial cell lines, two were macrophages and one was a fibroblast 
cell line. There is differential susceptibility to ECE for different cell types and this may be 
related to the cell type, the ECE or a combination of the two. 
 
There was a difference between the epithelial to the fibroblasts, the epithelial to the 
macrophages and the fibroblasts to the macrophages. However, this was not clear, with 
differences in response between different epithelial cell lines and different macrophage cell 
lines. The BEAS-2B cell line appeared to be the most sensitive of all the cells tested in this 
study. 
 
PMA treated THP-1 cells have been previously found to have a resistance to apoptotic 
stimuli which is comparable to primary human macrophage cell lines (Daigneault et al. 
2010). These were less susceptible to cytotoxicity in our experiments than the mouse 
macrophage J774. 
 
These data indicate that the cell line chosen to explore the cytotoxicity of ECs can 
influence the findings of studies in EC safety and toxicity testing. Thus there is still a need to 
standardise a testing protocol for an in vitro model of human airways with which to examine 
the potential health effects of ECE. 
 
 
Conclusions 
The aim of this study was to investigate the effects on viability of a variety of ECEs from 
different brands and with varying nicotine concentrations and flavourings. This was 
performed using four cell lines of relevance to the airways, namely bronchial epithelial cells 
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and macrophages, followed by further testing with additional epithelial, macrophage and 
fibroblast cell lines. A number of conclusions can be drawn from the results of this study.  
 
CSE has a dose-dependent detrimental impact on the cell viability across all four cell 
types tested. This was a good validation of the methodology employed in this study and sits 
well with the current and extensive literature. 
 
Nicotine concentration in ECs has little or no dose-dependent influence on the cell 
viability across all cell types. This again, appears to agree with the majority of the literature 
though this is a subject which is not fully explained in the current knowledge. 
 
The contents of different brands of EC and of different types within the same brand 
are very poorly defined. This is a concern since we show that EC flavourings can cause a 
significant decrease in cell viability, with fruit flavours especially resulting in greater 
cytotoxicity. We also show that cytotoxicity varies widely across brands, with identical 
descriptions of products, including flavour, resulting in significantly different effects on cell 
viability. 
 
And finally, the choice of cell line employed in the testing of ECs can result in 
significant differences in the outcome of the study. More work needs to be done to identify 
why this is the case. 
 
This study has allowed us to identify the cytotoxic effects of different brands and 
flavours of ECs using extracts in submerged cell culture. The next phase is to take the most 
cytotoxic ECs forward for testing on cultures at ALI. 
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Table 1. Manufacturer's information provided on the packaging of the cigarettes and five 
different EC brands (anonymised as A to E) used in the current study. 
Sample (type) Flavour 
Nicotine 
content 
Other additives / Information on packaging 
Cigarette N/A 0.8 mg 10 mg tar; 10 mg carbon monoxide 
A  
(EC) 
N/A 2.4 % / mL Water, polyethylene glycol, glycerine & flavours 
B 
(EC) 
Dark Cherry 
12.5 mg 
3.5 % v/v  
Dark cherry regular flavour 
Tobacco 
12.5 mg 
3.5 % v/v  
Tobacco flavour 
Crisp Mint 
12.5 mg 
3.5 % v/v  
Crisp mint flavour regular 
C 
(EC) 
Tobacco 1.8 % Propylene glycol, traces of nuts 
Menthol 1.8 % Propylene glycol, traces of nuts 
D 
(EC) 
Tobacco 
6 mg 
0.6 % 
Classic Tobacco flavour, propylene glycol 
Tobacco 
12 mg 
1.2 % 
Classic Tobacco flavour, propylene glycol 
Tobacco 
18 mg 
1.8 % 
Classic Tobacco flavour, propylene glycol 
E 
(EC) 
Apple 
16 mg 
1.6 % / mL 
Water, propylene glycol, glycerine and flavours. 
Traces of nuts 
Coffee 
16 mg 
1.6 % / mL 
Water, propylene glycol, glycerine and flavours. 
Traces of nuts 
Vanilla 
16 mg 
1.6 % / mL 
Water, propylene glycol, glycerine and flavours. 
Traces of nuts 
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Cherry 
16 mg 
1.6 % / mL 
Water, propylene glycol, glycerine and flavours. 
Traces of nuts 
Strawberry 
16 mg 
1.6 % / mL 
Water, propylene glycol, glycerine and flavours. 
Traces of nuts 
Tobacco 
16 mg 
1.6 % / mL 
Water, propylene glycol, glycerine and flavours. 
Traces of nuts 
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Table 2. Viability data as compared to control for the four main cell lines following exposure to varying concentrations (%) of ECE. Mean 
values are shown with standard deviations in brackets. Shaded boxes show cytotoxicity, i.e. viability which fell below 70% of control. 
Cell line C38 BEAS-2B IB3-1 J774 
Sample 
(type) 
Flavour 
Nicotine 
Content 
12.5 25 50 100 12.5 25 50 100 12.5 25 50 100 12.5 25 50 100 
A (EC)  - 2.4 % / mL 
95.5 
(5.9) 
91.0 
(5.4) 
90.6 
(4.7) 
88.5 
(4.6) 
89.6 
(7.5) 
85.7 
(7.6) 
85.4 
(7.6) 
84.8 
(7.5) 
89.7 
(4.2) 
89.6 
(3.9) 
88.5 
(4.1) 
79.2 
(3.7) 
99.7 
(4.5) 
99.4 
(5.9) 
98.9 
(2.7) 
77.9 
(3.5) 
B (EC) 
Dark Cherry 
12.5 mg 
3.5 % v/v 
98.6 
(5.4) 
93.9 
(5.4) 
89.2 
(3.7) 
89.5 
(4.4) 
94.3 
(7.3) 
92.1 
(7.6) 
86.1 
(7.2) 
81.5 
(7.6) 
90.6 
(7.1) 
90.9 
(7.0) 
92.3 
(6.5) 
83.6 
(6.3) 
97.6 
(3.6) 
97.2 
(4.7) 
96.9 
(2.9) 
88.7 
(2.9) 
Tobacco 
12.5 mg 
3.5 % v/v  
80.9 
(5.0) 
80.6 
(8.7) 
79.8 
(8.6) 
77.3 
(7.3) 
91.8 
(9.3) 
92.2 
(9.8) 
88.1  
(7.6) 
88.1  
(9.6) 
88.6 
(4.3) 
88.4 
(4.1) 
78.4 
(4.0) 
58.4 
(3.9) 
102.0 
(4.4) 
90.6 
(4.4) 
88.5 
(4.6) 
68.2 
(5.6) 
Crisp Mint 
12.5 mg 
3.5 % v/v  
95.5 
(3.6) 
94.6 
(5.7) 
93.1 
(3.7) 
93.1 
(4.7) 
92.3 
(4.2) 
90.8 
(4.1) 
89.9 
(4.6) 
82.3 
(2.7) 
88.3 
(4.0) 
87.4 
(4.2) 
89.3 
(3.7) 
79.1 
(4.4) 
89.6 
(4.2) 
91.2 
(5.1) 
90.1 
(5.8) 
80.2 
(4.8) 
C (EC) 
Tobacco 1.8 % 
90.3 
(5.2) 
92.3 
(6.7) 
83.4 
(6.9) 
72.9 
(6.4) 
92.1 
(5.5) 
85.1 
(5.8) 
54.8 
(8.9) 
22.4 
(3.7) 
88.5 
(4.8) 
89.1 
(4.1) 
89.7 
(3.4) 
78.0 
(4.2) 
90.0 
(3.8) 
89.9 
(4.0) 
89.4 
(4.1) 
91.2 
(3.8) 
Menthol 1.8 % 
89.4 
(8.9) 
89.8 
(6.9) 
87.9 
(7.5) 
83.2 
(5.4) 
89.6 
(5.7) 
89.3 
(5.1) 
87.7 
(6.2) 
83.9 
(5.5) 
89.5 
(3.8) 
87.1 
(9.9) 
88.2 
(2.6) 
89.5 
(3.0) 
91.4 
(4.4) 
90.2 
(4.2) 
88.7 
(3.9) 
89.1 
(5.3) 
D (EC) 
Tobacco 
6 mg 
0.6 % 
88.8 
(5.2) 
84.6  
(5.3) 
84.9 
(4.4) 
79.9 
(4.1) 
85.6 
(5.9) 
76.4 
(5.7) 
75.6 
(6.9) 
73.1 
(4.3) 
87.0 
(3.8) 
86.1 
(2.9) 
86.1 
(4.1) 
76.4 
(3.8) 
89.4 
(3.1) 
89.1 
(3.7) 
89.1 
(4.4) 
89.4 
(3.9) 
Tobacco 
12 mg 
1.2 % 
94.1 
(5.1) 
90.9 
(5.3) 
88.9 
(4.6) 
84.2 
(6.8) 
99.4 
(7.4) 
96.2 
(7.7) 
93.1 
(7.3) 
84.7 (6 
.7) 
98.4 
(4.7) 
99.3 
(3.9) 
99.9 
(3.4) 
88.8 
(3.0) 
99.7 
(2.8) 
98.3 
(5.3) 
98.2 
(3.6) 
88.2 
(2.5) 
Tobacco 
18 mg 
1.8 % 
93.3 
(5.6) 
86.4 
(5.7) 
85.2 
(5.1) 
84.6 
(5.1) 
95.7 
(2.9) 
90.3 
(4.2) 
89.3 
(3.7) 
88.6 
(4.2) 
89.7 
(3.7) 
89.2 
(3.8) 
91.1 
(3.3) 
77.9 
(3.0) 
89.5 
(2.9) 
89.8 
(4.4) 
91.1 
(4.3) 
77.1 
(6.3) 
E (EC) 
Apple 
16 mg 
1.6 % / mL 
87.4 
(4.5) 
81.9 
(4.6) 
78.2 
(4.6) 
74.4 
(5.6) 
95.5 
(7.4) 
92.4 
(5.6) 
90.2 
(8.6) 
83.8 
(7.6) 
86.0 
(3.5) 
84.7 
(2.9) 
79.5 
(2.9) 
75.8 
(3.0) 
87.6 
(3.0) 
87.6 
(3.6) 
85.1 
(3.2) 
76.6 
(2.8) 
Coffee 
16 mg 
1.6 % / mL 
89.3 
(5.4) 
87.9 
(4.8) 
87.3 
(4.0) 
86.7 
(4.1) 
92.0 
(5.1) 
91.5 
(5.5) 
91.9 
(3.9) 
87.1 
(3.7) 
90.1 
(4.5) 
89.9 
(3.9) 
89.4 
(4.1) 
79.8 
(3.1) 
93.1 
(4.3) 
90.8 
(4.4) 
90.9 
(3.8) 
79.9 
(3.8) 
Vanilla 
16 mg 
1.6 % / mL 
87.9 
(6.9) 
82.8 
(6.1) 
82.2 
(4.4) 
79.4 
(5.1) 
93.2 
(3.9) 
89.3 
(3.8) 
88.4 
(4.1) 
85.6 
(5.4) 
90.8 
(3.6) 
90.5 
(4.1) 
89.8 
(4.4) 
78.8 
(3.4) 
90.5 
(4.9) 
89.0 
(3.9) 
88.5 
(6.1) 
79.6 
(3.1) 
Cherry 
16 mg 
1.6 % / mL 
71.2 
(2.8) 
66.5 
(3.5) 
65.1 
(4.6) 
64.9 
(3.6) 
74.0 
(4.7) 
60.6 
(4.1) 
57.6 
(5.5) 
53.7 
(4.2) 
88.4 
(4.2) 
87.4 
(3.5) 
88.0 
(4.4) 
88.7 
(4.3) 
90.0 
(4.0) 
89.3 
(4.3) 
89.1 
(6.1) 
89.8 
(3.5) 
Strawberry 
16 mg 
1.6 % / mL 
67.9 
(4.9) 
63.3 
(4.2) 
49.2 
(3.8) 
47.5 
(4.7) 
56.2 
(3.8) 
46.3 
(3.7) 
45.1 
(4.3) 
43.6 
(3.6) 
90.6 
(3.9) 
87.5 
(3.3) 
78.9 
(4.0) 
66.9 
(2.8) 
90.7 
(4.4) 
88.3 
(3.2) 
79.3 
(4.2) 
68.9 
(4.0) 
Tobacco 
16 mg 
1.6 % / mL 
89.1 
(2.8) 
87.3 
(2.8) 
82.7 
(2.1) 
81.7 
(3.2) 
61.3 
(3.1) 
56.5 
(3.7) 
52.5 
(3.8) 
48.8 
(5.3) 
89.4 
(4.0) 
89.4 
(3.9) 
89.5 
(4.3) 
89.2 
(3.5) 
87.1 
(4.3) 
87.8 
(3.6) 
88.3 
(4.2) 
77.5 
(4.5) 
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Table 3. Statistical analysis of flavourings in the four cell lines employed. All values relate to 
the Two-way ANOVA p-value result of that flavour compared to the strawberry viability 
data. 
  ECE concentration (%) 
Cell line Comparison flavour 12.5 25 50 100 
IB3-1 Apple 0.0001 0.01 ns 0.0001 
Cherry 0.05 ns 0.0001 0.0001 
Tobacco ns ns 0.0001 0.0001 
C38 Apple 0.0001 0.0001 0.0001 0.0001 
Cherry ns ns 0.0001 0.0001 
Tobacco 0.0001 0.0001 0.0001 0.0001 
BEAS-2B Apple 0.0001 0.0001 0.0001 0.0001 
Cherry 0.0001 0.0001 0.0001 0.0001 
Tobacco 0.01 0.0001 0.0001 0.01 
J774 Apple 0.01 ns 0.0001 0.0001 
Cherry ns ns 0.0001 0.0001 
Tobacco 0.001 ns 0.0001 0.0001 
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Figure 1. Schematic diagram illustrating the experimental set-up used to produce extracts.  
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Figure 2. Effect of CSE on the viability of four different cell lines.  
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Figure 3. Effect of EVE on the viability of BEAS-2B.  
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Figure 4. Effect of increasing concentrations of nicotine in ECE on cell viability.  
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Figure 5. Effect of different flavours of ECE on cell viability. 
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Figure 6. Effect of different brands of tobacco flavoured ECE on cell viability.  
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Figure 1. CSE/ECE/EVE was prepared by bubbling the smoke/vapour from the cigarette or 
EC (1) through 10 mL of sterile culture medium (4). The sterile glass bottle (3) had an inlet 
tube (2) submerged in the medium to collect smoke/vapour and an outlet tube attached to the 
flow meter (5). A pump (6) attached to the power supply unit (7) was used to apply a vacuum 
for 2 s every 28 s, drawing air through the cigarette/EC and thus pulling smoke/EC vapour 
into the medium. The extract medium was transferred into a new sterile bottle, prior to its 
dilution, where appropriate, and addition to cells. 
 
Figure 2. CSE was prepared as described and diluted to 50, 25 and 12.5% in fresh sterile 
medium. 1 mL of the CSE was added to 3x10
5
 cells/mL/well of a 24 well plate and incubated 
for 24 hours, after which XTT was added to determine cell viability of IB3-1, C38, BEAS-2B 
and J774. Values are presented as the mean ± 1 S.D. of four individual experiments, with 
quadruplicate wells per experiment. Cell viability is expressed as a percentage of the control 
(untreated cells). Statistically significant differences (p<0.0001) compared to the control and 
between each serial dilution were demonstrated for all four cell lines.   
 
Figure 3. EVE was prepared as described at ratios of PG:G varying from 100:0 to 0:100. 1 
mL of the EVE was added to 3x10
5
 cells/mL/well of a 24 well plate and incubated for 24 
hours, after which XTT was added to determine cell viability. Values are presented as the 
mean ± 1 S.D. of four individual experiments, with quadruplicate wells per experiment. Cell 
viability is expressed as a percentage of the control (untreated cells). The 80:20 ratio was 
significant compared to every other ratio including the control. Similarly, 70:30 ratio was 
significantly different from 0:100, 30:70, 50:50 but not the control, 80:20 and 100:0, as 
shown on the graph. All others were non-significant with respect to the control and other 
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ratios (where * = p<0.05, ** = p<0.01, *** = p<0.001, **** = p<0.0001), however there was 
no ratio dependent effect.  
 
Figure 4. Vapour from each EC of different nicotine content was extracted as described 
previously and added to IB3-1, C38, BEAS-2B, J774 and THP-1 cell lines. 1 mL of the ECE 
was added to 3x10
5
 (2x10
5
 for THP-1) cells/mL/well of a 24 well plate and incubated for 24 
hours after which XTT was added to determine cell viability. Values are presented as the 
mean ± S.D. of four individual experiments, with quadruplicate wells per experiment. Cell 
viability is expressed as a percentage of the control (untreated cells). The minimum 
statistically significant differences are shown across each graph (where * = p<0.05, ** = 
p<0.01, *** = p<0.001, **** = p<0.0001) between each ECE and the control (where ns is 
non-significant). There was no nicotine strength dependence effect. 
 
Figure 5. IB3-1, C38, BEAS-2B and J774 cells were exposed to vapour extract from four 
different flavours of EC, with the same nicotine content (16 mg/mL). 1 mL of the ECE was 
added to 3x10
5
 cells/mL/well of a 24 well plate and incubated for 24 hours after which XTT 
was added to determine cell viability. Values are presented as the mean ± S.D. of four 
individual experiments, with quadruplicate wells per experiment. Cell viability is expressed 
as a percentage of the control (untreated cells). The minimum statistically significant 
differences are shown across each graph (where * = p<0.05, ** = p<0.01, *** = p<0.001, 
**** = p<0.0001) compared to control are shown for all four ECE tested (where ns is non-
significant). 
 
Figure 6. IB3-1, C38, BEAS-2B and J774 cells were exposed to ECE from four different 
brands of EC, all labelled as tobacco flavoured. 1 mL of the ECE was added to 3x10
5
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cells/mL/well of a 24 well plate and incubated for 24 hours after which XTT was added to 
determine cell viability. Values are presented as the mean ± S.D. of four individual 
experiments, with quadruplicate wells per experiment. Cell viability is expressed as a 
percentage of the control (untreated cells). The minimum statistically significant differences 
are shown across each graph (where * = p<0.05, ** = p<0.01, *** = p<0.001, **** = 
p<0.0001) compared to control are shown for all four ECE tested (where ns is non-
significant). 
 
 
 
 
 
 
 
